Paper · 42978697
Hupehenine suppresses tumor cell phenotypes and modulates macrophage marker profiles in a diabeticmimetic colorectal cancer model.
Zhu MQ and 9 others. Front Pharmacol, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hupehenine suppresses tumor cell phenotypes and modulates macrophage marker profiles in a diabeticmimetic colorectal cancer model. Papers, record 42978697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42978697
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hupehenine suppresses tumor cell phenotypes and modulates macrophage marker profiles in a diabeticmimetic colorectal cancer model.
- Journal
- Front Pharmacol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-05
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,216,283 | CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35216283 | PubMed |
| 2 | 37,062,440 | Tumor necrosis factor-α inhibitor-related autoimmune disorders. | Autoimmun Rev | 2023 | https://conductscience.org/library/papers/37062440 | PubMed |
| 3 | 36,875,619 | Transcriptomic and metabolomic analyses provide new insights into the appropriate harvest period in regenerated bulbs of Fritillaria hupehensis. | Front Plant Sci | 2023 | https://conductscience.org/library/papers/36875619 | PubMed |
| 4 | 39,191,336 | Metformin: From diabetes to cancer to prolongation of life. | Pharmacol Res | 2024 | https://conductscience.org/library/papers/39191336 | PubMed |
| 5 | 40,214,442 | The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis. | Cells | 2025 | https://conductscience.org/library/papers/40214442 | PubMed |
| 6 | 38,765,604 | Sipeimine ameliorates osteoarthritis progression by suppression of NLRP3 inflammasome-mediated pyroptosis through inhibition of PI3K/AKT/NF-κB pathway: An in vitro and in vivo study. | J Orthop Translat | 2024 | https://conductscience.org/library/papers/38765604 | PubMed |
| 7 | 33,249,087 | Biased agonism at chemokine receptors. | Cell Signal | 2021 | https://conductscience.org/library/papers/33249087 | PubMed |
| 8 | 40,058,151 | Novel CXCR2 antibodies exhibit enhanced anti-tumor activity in pancreatic cancer. | Biomed Pharmacother | 2025 | https://conductscience.org/library/papers/40058151 | PubMed |
| 9 | 40,520,203 | Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40520203 | PubMed |
| 10 | 36,708,902 | Integrated computational and experimental approach for novel anti-leishmanial molecules by targeting Dephospho-coenzyme A kinase. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/36708902 | PubMed |
1 to 10 of 33
See all 33 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42978697
GET https://conductscience.org/api/papers/v1/42978697/references?page=2